The Carter Center Ethiopia, Addis Ababa, Ethiopia.
Francis I Proctor Foundation, University of California, San Francisco, California, USA.
Trop Med Int Health. 2024 Oct;29(10):869-874. doi: 10.1111/tmi.14042. Epub 2024 Aug 14.
A 6-week course of tetracycline eye ointment is an alternative to single -dose oral azithromycin in annual mass drug administration for trachoma control. Compliance with the recommended tetracycline eye ointment regimen has not been well characterised when administered as part of a trachoma control program.
A routine mass drug administration for trachoma was carried out in 40 communities in the Amhara region of Ethiopia. Two tubes of tetracycline eye ointment, to be administered twice daily for 6 weeks, was offered to all children under 6 months of age, to pregnant women who declined to take azithromycin, and to all individuals with a macrolide allergy. Seven weeks following the mass drug administration, a treatment compliance survey was performed for all community members documented to have received tetracycline eye ointment during the mass drug administration.
Of the 491 individuals documented as having received tetracycline eye ointment from the treatment records, 367 completed the survey, of which 214 recalled being offered tetracycline eye ointment. A total of 105 (49%) respondents reported taking ≥1 daily dose of tetracycline eye ointment on most days of the week for at least the first week. Only 20 (9%) respondents reported taking at least 1 tetracycline eye ointment dose per week for 6 weeks. The most common reasons for low compliance included 'saving it for a future infection' and 'stopped because I (or my child) seemed healthy'. The odds of low compliance were greater for those who reported not having adequate counselling (e.g., odds ratio [OR] 5.3, 95% CI 2.5-28.9 when low compliance was defined as not taking a tetracycline eye ointment dose for most days of at least the first week).
Compliance with tetracycline eye ointment was low when administered by a trachoma program during a routine mass drug administration, especially for those reporting inadequate counselling. Further research with a larger sample size and varied settings is warranted to better understand and improve compliance.
在沙眼控制的年度大规模药物治疗中,6 周疗程的四环素眼膏替代单剂量口服阿奇霉素。当作为沙眼控制规划的一部分给予时,四环素眼膏推荐方案的依从性尚未得到很好的描述。
在埃塞俄比亚阿姆哈拉地区的 40 个社区中进行了常规的大规模药物治疗。向所有 6 个月以下的儿童、拒绝服用阿奇霉素的孕妇以及所有对大环内酯类药物过敏的人提供两管四环素眼膏,每天两次,持续 6 周。大规模药物治疗后 7 周,对所有记录在案的在大规模药物治疗期间接受过四环素眼膏治疗的社区成员进行了治疗依从性调查。
在治疗记录中记录的 491 名接受过四环素眼膏治疗的人中,有 367 人完成了调查,其中 214 人回忆曾被提供过四环素眼膏。共有 105 人(49%)报告说,在一周的大多数日子里,每天至少服用 1 次四环素眼膏。只有 20 人(9%)报告说,在 6 周内每周至少服用 1 次四环素眼膏。低依从性的最常见原因包括“留作将来感染”和“因为我(或我的孩子)似乎健康而停止”。那些报告说没有得到足够咨询的人低依从性的可能性更大(例如,当低依从性定义为在至少第一周的大多数日子里没有服用四环素眼膏剂量时,低依从性的比值比[OR]为 5.3,95%CI 为 2.5-28.9)。
在常规大规模药物治疗中,通过沙眼方案给予四环素眼膏时,依从性很低,特别是那些报告咨询不足的患者。需要进一步开展更大规模和不同环境的研究,以更好地了解和提高依从性。